UA70961C2 - ТРИЦИКЛІЧНІ <font face="Symbol">D</font>3-ПІПЕРИДИНИ, КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА СПОСІБ ЇХ ОДЕРЖАННЯ (ВАРІАНТИ) - Google Patents

ТРИЦИКЛІЧНІ <font face="Symbol">D</font>3-ПІПЕРИДИНИ, КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА СПОСІБ ЇХ ОДЕРЖАННЯ (ВАРІАНТИ)

Info

Publication number
UA70961C2
UA70961C2 UA2001032000A UA01032000A UA70961C2 UA 70961 C2 UA70961 C2 UA 70961C2 UA 2001032000 A UA2001032000 A UA 2001032000A UA 01032000 A UA01032000 A UA 01032000A UA 70961 C2 UA70961 C2 UA 70961C2
Authority
UA
Ukraine
Prior art keywords
preparation
piperidines
tricyclic
variants
composition based
Prior art date
Application number
UA2001032000A
Other languages
English (en)
Russian (ru)
Inventor
Людо Едмон Жозефін Кенніс
Людо Эдмон Жозефин Кеннис
Жозефус Каролус МЕРТЕНС
Міреї Брекен
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of UA70961C2 publication Critical patent/UA70961C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Даний винахід стосується сполук загальної формули (І), їх N-оксидних форм, фармацевтично прийнятних адитивних солей та стереохімічно ізомерних форм, де Alk являє собою С1-6алкандіїл; n являє собою 1 або 2; Х являє собою -О-, -S-, -S(=O)- або -S(=O)2-; кожний R1 незалежно являє собою водень, галоген, С1-4алкілокси, нітро, гідрокси або С1-4алкілокси; D являє собою індол, бензізоксазол, бензізотіазол, 2Н-бензопіранон, феноксифеніл, бензамід, бензофенон або бензопіримідинон, що мають антагоністичну активність по відношенню до центрального -адреноцептора. Також винахід відноситься до їх препаратів, фармацевтичного застосування та композицій.
UA2001032000A 1998-10-06 1999-10-01 ТРИЦИКЛІЧНІ <font face="Symbol">D</font>3-ПІПЕРИДИНИ, КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА СПОСІБ ЇХ ОДЕРЖАННЯ (ВАРІАНТИ) UA70961C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203371 1998-10-06
PCT/EP1999/007420 WO2000020423A1 (en) 1998-10-06 1999-10-01 Tricyclic δ3-piperidines as pharmaceuticals

Publications (1)

Publication Number Publication Date
UA70961C2 true UA70961C2 (uk) 2004-11-15

Family

ID=8234192

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2001032000A UA70961C2 (uk) 1998-10-06 1999-10-01 ТРИЦИКЛІЧНІ <font face="Symbol">D</font>3-ПІПЕРИДИНИ, КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА СПОСІБ ЇХ ОДЕРЖАННЯ (ВАРІАНТИ)

Country Status (28)

Country Link
US (1) US6352999B1 (uk)
EP (1) EP1119570B1 (uk)
JP (1) JP4590102B2 (uk)
KR (1) KR20010071844A (uk)
CN (1) CN1131868C (uk)
AR (1) AR023679A1 (uk)
AT (1) ATE269337T1 (uk)
AU (1) AU759199B2 (uk)
BG (1) BG64871B1 (uk)
BR (1) BR9913108A (uk)
CA (1) CA2346082C (uk)
CZ (1) CZ20011105A3 (uk)
DE (1) DE69918148T2 (uk)
EE (1) EE04680B1 (uk)
ES (1) ES2222735T3 (uk)
HK (1) HK1038009A1 (uk)
HU (1) HUP0103749A3 (uk)
ID (1) ID28451A (uk)
IL (2) IL142444A0 (uk)
NO (1) NO20011402D0 (uk)
NZ (1) NZ510116A (uk)
PL (1) PL347179A1 (uk)
RU (1) RU2226194C2 (uk)
SK (1) SK285386B6 (uk)
TR (1) TR200100953T2 (uk)
TW (1) TWI244485B (uk)
UA (1) UA70961C2 (uk)
WO (1) WO2000020423A1 (uk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
CA2451606A1 (en) 2001-07-05 2003-01-16 Pharmacia & Upjohn Company (hetero) aryl substituted benzofurans as 5-ht ligands
ATE521593T1 (de) * 2002-04-03 2011-09-15 Orion Corp Verwendung eines alfa2-adrenorezeptorantagonisten bei mit dem zns zusammenhängenden erkrankungen
MXPA06011777A (es) 2004-04-12 2007-01-16 Taisho Pharma Co Ltd Compuesto de amina ciclico.
GT200600078A (es) 2005-02-17 2007-04-12 Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquil condensados
DE102005038947A1 (de) * 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
JP6392344B2 (ja) * 2013-07-25 2018-09-19 ドン−ア エスティ カンパニー リミテッド ベンズアミド誘導体の製造方法、その製造に使用される新規な中間体及び該中間体の製造方法
CN103755715B (zh) * 2013-12-26 2015-12-09 武汉理工大学 苯并呋喃并[2,3-c]吡啶化合物及其合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3522959A1 (de) * 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US4985422A (en) * 1988-04-27 1991-01-15 Glaxo Group Limited Lactam derivatives
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
ATE207071T1 (de) * 1996-12-06 2001-11-15 Abbott Lab Benzopyranopyrrole und benzopyranopyridine mit alpha-1 adrenergische wirkung
UA52681C2 (uk) 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ

Also Published As

Publication number Publication date
AU6334299A (en) 2000-04-26
EP1119570B1 (en) 2004-06-16
IL142444A0 (en) 2002-03-10
DE69918148T2 (de) 2005-07-28
JP4590102B2 (ja) 2010-12-01
JP2002526547A (ja) 2002-08-20
DE69918148D1 (de) 2004-07-22
NO20011402L (no) 2001-03-20
CA2346082A1 (en) 2000-04-13
EE04680B1 (et) 2006-08-15
AU759199B2 (en) 2003-04-10
EP1119570A1 (en) 2001-08-01
AR023679A1 (es) 2002-09-04
TWI244485B (en) 2005-12-01
IL142444A (en) 2008-03-20
TR200100953T2 (tr) 2001-09-21
HK1038009A1 (en) 2002-03-01
WO2000020423A1 (en) 2000-04-13
ID28451A (id) 2001-05-24
ES2222735T3 (es) 2005-02-01
SK285386B6 (sk) 2006-12-07
CN1321158A (zh) 2001-11-07
EE200100210A (et) 2002-06-17
HUP0103749A3 (en) 2003-03-28
SK4332001A3 (en) 2001-12-03
NZ510116A (en) 2002-10-25
ATE269337T1 (de) 2004-07-15
CZ20011105A3 (cs) 2001-12-12
BR9913108A (pt) 2001-05-08
CN1131868C (zh) 2003-12-24
PL347179A1 (en) 2002-03-25
NO20011402D0 (no) 2001-03-20
CA2346082C (en) 2010-02-16
RU2226194C2 (ru) 2004-03-27
US6352999B1 (en) 2002-03-05
BG105334A (en) 2001-11-30
BG64871B1 (bg) 2006-07-31
KR20010071844A (ko) 2001-07-31
HUP0103749A2 (hu) 2002-02-28

Similar Documents

Publication Publication Date Title
BR9915403A (pt) Antagonistas receptores iii de 4-aroil-piperidin-ccr-3
BR9915735A (pt) Antagonistas receptores de ccr-3 de piperidina
BR9916980A (pt) Derivados bicìclicos substituìdos úteis como agentes anticancerìgenos
BR9913575A (pt) Composições compreendendo sais de amina simpatomimética inadequadas para uso ilegal
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
JO2371B1 (en) 4-phenyl-pyridine derivatives
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
IL145429A0 (en) N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
CA2360313A1 (en) Glucocorticoid receptor modulators
BR0213452A (pt) Derivados de piperazina com atividade antagonista receptora de ccr1
CA2360308A1 (en) Glucocorticoid receptor modulators
MXPA04003192A (es) Sales de acido succinico de 5, 7, 14-triazatetraciclo ?10.3.1.02,11.04,9? -hexadeca-2(11), 3, 5, 7, 9-pentaeno y composiciones farmacetucias de las mismas.
IS2789B (is) Lyfjablöndur sem innihalda mónóamínoxídasa B hemla
BG104630A (en) Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
NO20040589L (no) Arylsulfonylderivater med 5-HT6 reseptor affinitet.
UA70961C2 (uk) ТРИЦИКЛІЧНІ &lt;font face=&#34;Symbol&#34;&gt;D&lt;/font&gt;3-ПІПЕРИДИНИ, КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА СПОСІБ ЇХ ОДЕРЖАННЯ (ВАРІАНТИ)
TNSN04024A1 (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
IS5501A (is) Samsetningar og aðferðir til að auka styrkinn og/eða hreyfanleikan hjá sæðisfrumum í manneskjum
IL134894A (en) 2-substituted-1,3,4,5-tetrahydro-2h-gamma-carbolines, their preparation and pharmaceutical compositions containing them
CA2345622A1 (en) Tricyclic .delta.3-piperidines as .alpha.2-antagonists
MY120033A (en) 1,2,3,4- tetrahydro- benzofuro[3,2-c] pyridine derivatives
EP1019047A4 (en) ANTITHROMBOTIC AGENTS
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
ES2172376A1 (es) Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.